Artículos originales \ Editorial
Complete revascularization and diabetes in the real world: observational data as a necessary addition to clinical trials
Servicio de Cardiología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
REC Interv Cardiol. 2022;4:267-268
Management of coronary artery perforations during chronic total coronary occlusion percutaneous coronary intervention
Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
REC Interv Cardiol. 2022;4:269-270
Bayesian vs frequentist statistics: afraid of losing the reference?
aServicio de Cardiología, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
bCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain
cDepartamento de Matemática Aplicada, Instituto Universitario de Matemáticas y Aplicaciones (IUMA), Universidad de Zaragoza, Zaragoza, Spain
REC Interv Cardiol. 2022;4:167-168
The need for a Spanish registry of interventional procedures to treat congenital heart disease and standards for center accreditation
aServicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain
bServicio de Cardiología Pediátrica, Hospital Universitario La Paz, Madrid, Spain
REC Interv Cardiol. 2022;4:165-166
The role of percutaneous tricuspid regurgitation interventions in the current clinical practice: tackling a heterogenous disease
aDivision of Cardiology, Montefiore Medical Center, Albert Einstein School of Medicine, New York, NY, United States
bSackler Faculty of Medicine, Tel-Aviv University, Israel
cDivision of Cardiology, Department of Medicine, University of Cape Town, Cape Town, South Africa
REC Interv Cardiol. 2022;4:169-172
Stent delivery during primary angioplasty: speed doesn’t matter
aDivision of Cardiology Ospedale degli Infermi, ASL Biella, Biella, Italy
bDepartment of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
cDepartment of Cardiology, AOU “Maggiore della Carità”, Novara, Italy
REC Interv Cardiol. 2022;4:87-88
Utility of the pressure guidewire in diabetic patients
aÀrea de Malalties del Cor (Bio-Heart), Hospital Universitari de Bellvitge, L´Hospitalet de Llobregat, Barcelona, Spain
bInstitut de Recerca Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
REC Interv Cardiol. 2022;4:89-90
Small margins and big gains: evidence for angioplasty with cutting or scoring balloons in patients with in-stent restenosis
aCardiovascular Research Institute (CVRI) Dublin, Mater Private Network, Dublin, Ireland
bSchool of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
REC Interv Cardiol. 2022;4:4-5
Limitations of angiography in the detection of target lesion calcium. No significant differences today compared to 1995
Cardiovascular Research Foundation, New York, United States
REC Interv Cardiol. 2022;4:1-3
New drug-eluting stents: technological refinement continues
aServicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain
bServicio de Cardiología, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
REC Interv Cardiol. 2021;3:247-249
Page 3 of 7